Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Early Onset Scoliosis

NCT03519321 is registered in ClinicalTrials.gov with Apifix as lead sponsor.

NCT NCT03519321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Early Onset Scoliosis
Lead sponsor
Apifix
Phase
Not applicable
Overall status
Unknown status
Start date
April 11, 2018
Completion date
July 20, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scoliosis, scoliosis idiopathic, scoliosis;congenital